| Market Cap | ₹895Cr |
| ROE | 13.86% |
| P/E Ratio(TTM) | 38.78 |
| EPS(TTM) | 27.91 |
| P/B Ratio | 5.38 |
| Dividend Yield | 0.18% |
| Industry P/E | 33.18 |
| Book Value | 201.38 |
| Debt to Equity | 0.05 |
| Face Value | 10 |
| Parent Organisation | Titan Biotech Limited |
| Managing Director | Mr. Naresh Kumar Singla, Mr. Suresh Chand Singla |
| Founded | 1992 |
| BSE Symbol | 524717 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Biocon | NA (0.00%) | 68.80 | ||
| Anthem Biosciences | NA (0.00%) | 72.79 | ||
| Onesource Specialty Pharma | NA (0.00%) | 472.59 | ||
| Advanced Enzyme Technologies | NA (0.00%) | 22.55 |